Exelixis Inc

27 oct 2026, 19:36 UTC

Exelixis Inc is trading slightly higher, maintaining its position above the 20-day moving average and near the upper end of its one-month trading range.

26 oct 2026, 20:07 UTC

Exelixis Inc shares are advancing amid a broader market rally, supported by positive economic indicators including the Dallas Fed Manufacturing Index exceeding expectations.

23 oct 2026, 20:07 UTC

Exelixis Inc shares are declining amid a broadly lower market, reflecting rising oil prices, inflation concerns, and geopolitical tensions affecting investor sentiment.

21 oct 2026, 19:26 UTC

Exelixis Inc shares are trading slightly higher, supported by positive momentum in the broader biotechnology sector, despite an earlier pullback from a session high.

20 oct 2026, 20:08 UTC

Exelixis Inc shares advanced, closing significantly higher and reaching a notable peak, remaining well above its 20-day moving average.

19 oct 2026, 20:07 UTC

Citizens maintains Market Outperform rating on Exelixis and raises price target to $65, contributing to a modest gain in the stock.

16 oct 2026, 19:16 UTC

Exelixis Inc shares fell significantly from an early high, remaining above the 20-day moving average despite today's notable decline.

15 oct 2026, 20:07 UTC

Exelixis Inc shares advanced, continuing a trend of gains since Wednesday's close, remaining significantly above its 20-day moving average despite an earlier pullback.

14 oct 2026, 19:16 UTC

Exelixis Inc shares are advancing, reaching a notable peak in early afternoon trading and positioned well above its 20-day moving average.

13 oct 2026, 20:08 UTC

Exelixis Inc shares are modestly lower, retracing from an early gain, amid a broader market decline.

12 oct 2026, 21:02 UTC

Exelixis Inc shares declined in after-market trading, continuing lower since Monday's close and diverging from a recent trend of higher daily closes.

9 oct 2026, 20:06 UTC

RBC Capital raised its price target on Exelixis Inc to $51 while maintaining a Sector Perform rating, coinciding with the stock's positive performance.

8 oct 2026, 20:07 UTC

Exelixis Inc's shares advanced, supported by broader market strength, maintaining an upward trajectory despite an earlier pullback from a session high.

7 oct 2026, 19:45 UTC

Exelixis Inc shares are trading higher as Truist Securities raises the price target to $54.00 from $52.00 while maintaining a Hold rating.

6 oct 2026, 21:01 UTC

Exelixis Inc is trading modestly lower in after-market hours, positioned around the midpoint of its one-month trading range.

5 oct 2026, 21:10 UTC

Exelixis Inc. is advancing in after-market trading, closing at its highest point of the day after three consecutive sessions of gains.

2 oct 2026, 20:00 UTC

Exelixis Inc shares are advancing, reaching a peak cumulative return and remaining well above their 20-day moving average during Friday's market session.

1 oct 2026, 20:07 UTC

Exelixis Inc's shares fell modestly, reflecting routine performance amid broader market conditions, and are currently near the low end of their daily range.

30 sept 2026, 23:20 UTC

Exelixis Inc shares are higher in after-market trading, continuing a five-day gain, supported by strong Q2 GDP growth despite mixed inflation and consumer spending signals.

29 sept 2026, 20:31 UTC

Exelixis Inc saw a significant decline in after-market trading, continuing a downward trend since Tuesday's close following earlier gains.

28 sept 2026, 19:16 UTC

Exelixis Inc is trading modestly higher, currently 2.25% above its 20-day moving average, reflecting routine activity for this time of day.

25 sept 2026, 23:20 UTC

Exelixis Inc is lower in after-market trading, retracing from an early gain and reflecting a decline since Friday's close.

24 sept 2026, 20:01 UTC

Exelixis Inc is advancing, peaking in mid-afternoon while remaining above its 20-day moving average and near the upper end of its one-month range.

23 sept 2026, 20:07 UTC

Exelixis Inc shares fell significantly on Wednesday, having briefly spiked earlier in the session, reflecting a lack of momentum in either direction.

22 sept 2026, 20:06 UTC

Exelixis Inc is gaining today, building on Monday's momentum, with the stock remaining above its 20-day moving average and near its one-month range's upper end.

21 sept 2026, 23:25 UTC

Exelixis Inc is trading modestly lower in after-market hours, continuing a decline seen over the past three sessions after reaching a session high.

18 sept 2026, 20:06 UTC

Exelixis Inc's shares fell sharply after reaching a notable peak earlier in the session, while remaining above the 20-day moving average.

16 sept 2026, 20:07 UTC

Exelixis Inc shares fell sharply, retracing from an early peak in cumulative return amid unusually high market volume on Wednesday.

15 sept 2026, 20:07 UTC

Exelixis Inc. shares are higher as the company expands CABOMETYX in renal cell carcinoma and neuroendocrine tumors, reflecting investor confidence amid broader market concerns.

14 sept 2026, 20:07 UTC

Exelixis shares are rising after BMO indicated the FDA's PDUFA date extension for Zanzalintinib is procedural, maintaining a $55 price target.